GlassScriptPhysician profile
Camille I Folkard
NPI 1336581735
$3,200.86
in general payments reported to CMS, 2019-2025
38 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2022: $431 · 2023: $810 · 2024: $791 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,347.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $568.62 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Medtronic, INC. | $382.64 | 2023-2025 | Minimed 780g, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $285.65 | 2019-2023 | Farxiga |
| Abbvie INC. | $274.66 | 2019-2025 | |
| Amgen INC. | $213.68 | 2024-2025 | Tepezza, Evenity, Prolia |
| Boston Scientific Corporation | $172.66 | 2024-2025 | Spyglass, Apollo Esg System |
| Pfizer INC. | $121.13 | 2023-2025 | |
| Lilly USA, LLC | $119.48 | 2022-2024 | Jardiance, Baqsimi, Lyumjev |
| Abbott Laboratories | $105.43 | 2022-2024 | Freestyle Libre 3 |
| Mannkind Corporation | $88.88 | 2022-2024 | Afrezza |
| Radius Health, INC. | $73.79 | 2023 | Tymlos |
| Embecta Corp. | $67.93 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Bayer Healthcare Pharmaceuticals INC. | $63.91 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.92 | 2022-2024 | Jardiance |
| Amarin Pharma, INC. | $48.65 | 2022-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camille Folkard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.